Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Language Row Costs Pharmacist: Action Ordered for Giving Wrong Medicine, Refusing Bengali

Provide additional financial aid for Una Bulk Drug Park: Himachal CM urges J P Nadda

Written By Ruchika Sharma20 July 2024 2:39 PM IST

Shimla: Chief Minister Sukhvinder Singh Sukhu has appealed to Union Health Minister J.P. Nadda for additional financial aid towards the...

Aurobindo Pharma arm Unit IV gets 5 USFDA observations

Zydus Lifesciences gets 2 USFDA observations for Ahmedabad transdermal manufacturing site

Written By Ruchika Sharma20 July 2024 11:30 AM IST

Ahmedabad: Zydus Lifesciences has received 2 observations from the US Food and Drug Administration (USFDA) at the closure of the inspection at...

Divi's Labs gets one USFDA observation for Visakhapatnam facility

Written By Ruchika Sharma19 July 2024 5:28 PM IST

Telangana: Divi's Laboratories Limited has received one procedural observation from the US Food and Drug Administration (USFDA) at the...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

Caplin Steriles gets USFDA nod for Ephedrine Sulfate injection

Written By Ruchika Sharma19 July 2024 4:28 PM IST

Chennai: Caplin Steriles Limited, a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval by the United States Food...

USFDA nod to Zydus Lifesciences diabetes drug

Written By Ruchika Sharma19 July 2024 3:17 PM IST

Ahmedabad: Zydus Lifesciences Limited has received final approval for its New Drug Application (NDA) from the United States Food and Drug...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

Zydus Lifesciences gets USFDA OAI status for Jarod facility

Written By Ruchika Sharma19 July 2024 12:49 PM IST

Ahmedabad: Zydus Lifesciences has informed in a BSE filing that the United States Food and Drug Administration (USFDA) has determined...

AstraZenecas Imfinzi Combo Shows Strong Survival Benefit in Liver Cancer Trial

AstraZeneca concludes acquisition of Amolyt Pharma

Written By Ruchika Sharma17 July 2024 11:30 AM IST

Cambridge: AstraZeneca has announced the successful completion of the acquisition of Amolyt Pharma, a clinical-stage biotechnology company...

SII high efficacy malaria vaccine launched in Africa

Written By Ruchika Sharma16 July 2024 5:03 PM IST

New Delhi: A new vaccine for malaria jointly developed by the Serum Institute of India (SII) and the University of Oxford was officially...

After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug Nereus

Lupin gets USFDA tentative nod for Sodium Sulfate, Magnesium Sulfate, Potassium Chloride Tablets

Written By Ruchika Sharma16 July 2024 3:27 PM IST

Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults.

Granules India packaging facility in US successfully completes USFDA inspection

Unichem Labs gets 5 USFDA observations for Goa facility

Written By Ruchika Sharma16 July 2024 12:30 PM IST

Mumbai: Unichem Labs has received five observations from the United States Food and Drug Administration (USFDA) at the closure of the inspection...

Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing Plant

Lupin divests US Commercial Women Health Specialty Business to Evofem Biosciences for nearly USD 84 million

Written By Ruchika Sharma16 July 2024 11:48 AM IST

Mumbai: Global pharma major Lupin Limited has announced that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem...

Diabetologists urge free devices for children with Type 1 diabetes

Written By Ruchika Sharma15 July 2024 4:39 PM IST

Thiruvananthapuram: In a resounding call for equitable healthcare access, diabetologists from India and international faculty members...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok